Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology ...
For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology ...
Venture capital firms are still raising money, but they’re not raising as much as they used to and it’s taking ...
New research reveals that ultra-processed foods account for nearly half of US household grocery purchases, with lower-income and less-educated families ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
WASHINGTON — One of Robert F. Kennedy Jr.’s longtime dreams seems to be coming true: He’s on a potentially winning ...
Scott: A lot of parents raise kids to be independent. I think that’s a mistake. You do not want to ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.